Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Sara Galluzzo

PML as a Potential Predictive Factor of Oxaliplatin/Fluoropyrimidine-Based First Line Chemotherapy Efficacy in Colorectal Cancer Patients

Journal of Cellular Physiology

Clinical Biochemistry

Cell Biology

Physiology

2011

English

Related publications

Intratumoral COX-2 Gene Expression Is a Predictive Factor for Colorectal Cancer Response to Fluoropyrimidine-Based Chemotherapy

Clinical Cancer Research

Cancer Research

Oncology

2005

English

Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer

Journal of IMAB - Annual Proceeding (Scientific Papers)

Dentistry

2011

English

Role of RAS Mutation Status as a Prognostic Factor for Patients With Advanced Colorectal Cancer Treated With First-Line Chemotherapy Based on Fluoropyrimidines and Oxaliplatin, With or Without Bevavizumab: A Retrospective Analysis

Molecular and Clinical Oncology

Cancer Research

Oncology

2017

English

Reply: Oxaliplatin- Or Irinotecan-Based Chemotherapy for Metastatic Colorectal Cancer in the Elderly

British Journal of Cancer

Cancer Research

Oncology

2004

English

Oxaliplatin, 5-Fluorouracil and Leucovorin (Modified FOLFOX-6) as First-Line Chemotherapy for Advanced Gastric Cancer Patients With Poor Performance Status

English

Predictive Value of TLR7 Polymorphism for Cetuximab-Based Chemotherapy in Patients With Metastatic Colorectal Cancer

International Journal of Cancer

Cancer Research

Oncology

2017

English

Efficacy of Continued Cetuximab for Unresectable Metastatic Colorectal Cancer After Disease Progression During First-Line Cetuximab-Based Chemotherapy: A Retrospective Cohort Study

Oncotarget

Oncology

2016

English

Phase II Study of Gemcitabine Plus Oxaliplatin as First-Line Chemotherapy for Advanced Non-Small-Cell Lung Cancer

British Journal of Cancer

Cancer Research

Oncology

2005

English

Phase I Trial of Oxaliplatin Plus S-1 Chemotherapy in Patients With Metastatic Colorectal Cancer

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Sara Galluzzo

PML as a Potential Predictive Factor of Oxaliplatin/Fluoropyrimidine-Based First Line Chemotherapy Efficacy in Colorectal Cancer Patients

Related publications

Intratumoral COX-2 Gene Expression Is a Predictive Factor for Colorectal Cancer Response to Fluoropyrimidine-Based Chemotherapy

Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer

Role of RAS Mutation Status as a Prognostic Factor for Patients With Advanced Colorectal Cancer Treated With First-Line Chemotherapy Based on Fluoropyrimidines and Oxaliplatin, With or Without Bevavizumab: A Retrospective Analysis

Reply: Oxaliplatin- Or Irinotecan-Based Chemotherapy for Metastatic Colorectal Cancer in the Elderly

Oxaliplatin, 5-Fluorouracil and Leucovorin (Modified FOLFOX-6) as First-Line Chemotherapy for Advanced Gastric Cancer Patients With Poor Performance Status

Predictive Value of TLR7 Polymorphism for Cetuximab-Based Chemotherapy in Patients With Metastatic Colorectal Cancer

Efficacy of Continued Cetuximab for Unresectable Metastatic Colorectal Cancer After Disease Progression During First-Line Cetuximab-Based Chemotherapy: A Retrospective Cohort Study

Phase II Study of Gemcitabine Plus Oxaliplatin as First-Line Chemotherapy for Advanced Non-Small-Cell Lung Cancer

Phase I Trial of Oxaliplatin Plus S-1 Chemotherapy in Patients With Metastatic Colorectal Cancer